Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
World Journal of Gastroenterology|November 18, 2014
Covert hepatic encephalopathy: agreement and predictive validity of different indicesSara Montagnese, Esmeralda Balistreri, Sami Schiff, et al.
European Journal of Endocrinology|May 1, 2002
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetesMichele Dalla Vestra, David Sacerdoti, Giancarlo Bombonato, et al.
World Journal of Gastroenterology|November 6, 2008
Natural heme oxygenase-1 inducers in hepatobiliary functionGiovanni Li Volti, David Sacerdoti, Claudia Di Giacomo, et al.
Journal of Nutrition and Metabolism|October 25, 2017
Heme Oxygenase Induction Suppresses Hepatic Hepcidin and Rescues Ferroportin and Ferritin Expression in Obese MiceNitin Puri, Yevgeniy Arefiev, Robert Chao, et al.
Journal of Digestive Diseases|June 14, 2022
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experienceAndrea Dalbeni, Rosanna Villani, Michele Bevilacqua, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosisLuigi Bolondi, Fabio Piscaglia, Angelo Gatta, et al.
Annals of Hepatology|October 15, 2019
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3Gianmarco Villano, Alberto Verardo, Andrea Martini, et al.
Internal and Emergency Medicine|June 2, 2023
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning applicationMirko Zoncapè, Michele Carlin, Manuele Bicego, et al.
The Journal of Clinical Investigation|May 3, 2014
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagyTania Zaglia, Giulia Milan, Aaron Ruhs, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 21, 2022
Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertensionFilippo Cattazzo, Rosa Lombardi, Anna Mantovani, et al.
Pageof 9